Solution d'hydroxyde de sodium 50 %, extra pure, 1 l, emballage plastique.

2-Chloro-N-(3,5-dimethyl-phenyl)-acetamide, 95.0%, 5g

6-Chlorouracil, 98.0%, 100g

2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)azetidin-3-yl)acetic acid, 98%, 250mg

Ethyl 2-cyano-2-phenylbutanoate, 95.0%, 10g

N-(2-(3,5-Dichlorophenyl)propan-2-yl)acetamide, 95%, 100mg

4-Chloro-3-(diethylsulfamoyl)benzoic acid, 97%, 100mg

o-Acetanisidide>98.0%(HPLC)(N)25g

7-Bromo-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazine, 96%, 250mg

4-Amino-2-fluoro-5-methoxybenzoic acid, 95.0%, 5g

3-methyl-5-[(2S)-2-pyrrolidinyl]-1,2,4-oxadiazole hydrochloride, 95.0%, 1g

1-Pentanol, min.98%, pour la synthèse, 1 L, emballage en verre

1-(tert-Butyl) 2-ethyl 4-oxopiperidine-1,2-dicarboxylate, 250mg